Disclosure made under regulation 31(4) of SEBI LORD Regulation
Awaiting price reaction for this filing.
ADS Diagnostics has filed a Regulation 31(4) declaration with BSE for FY ending March 31, 2025. Four promoter group members — Radhika Sehgal, Versha Sehgal, Vivek Sehgal, and Dr. Gautam Sehgal — have confirmed that no member of the promoter or promoter group (including persons acting in concert) has created any encumbrance, directly or indirectly, on the company's shares during the financial year. The letter is dated 13th May 2025 and is addressed to both BSE and the company secretary. This is a routine annual compliance disclosure required when promoters have not pledged any shares.
This is a neutral, routine compliance filing. No new pledge, invocation, or release event is reported — promoter holdings remain unencumbered for FY25. Shareholders should treat this as a confirmation of stability in promoter shareholding rather than a trigger for any price movement.